Implementation of behavioral "nudges" targeting non–guideline-concordant antibiotic prescribing helped reduce inappropriate prescribing for respiratory tract infections at three California urgent care centers (UCCs), researchers reported last week in Open Forum Infectious Diseases.
A study yesterday in the Annals of Internal Medicine of more than 2,000 Europeans diagnosed as having mild to moderate COVID-19 shows that 87% reported loss of smell, and 56% reported taste dysfunction. The study suggests olfactory symptoms and taste disorders may be a common feature of COVID-19 infection.
Four countries in the Middle East and Africa reported a total of nine new cases this week, according to the latest update from the Global Polio Eradication Initiative (GPEI).
US drug maker Pfizer Inc. and Germany biopharmaceutical company BioNTech announced today that the first US participants in a clinical trial for a novel coronavirus vaccine have begun receiving doses.
Public campaigns that use "fear-based" messaging to reduce antibiotic use and antimicrobial resistance (AMR) may be more effective if they also contain messages that empower patients to self-manage without antibiotics, UK researchers reported in a study published today in BMC Medicine.
A paper yesterday in Current Opinion in Virology highlights a new effort led by the Center for Infectious Disease Research and Policy (CIDRAP) to track the development of universal influenza vaccine technologies.
In a snapshot of MERS-CoV cases in Saudi Arabia in February, the country reported 18 cases, 5 of them fatal, from 9 different cities, the World Health Organization (WHO) said yesterday.
Seqirus's cell-cultured quadrivalent (four-strain) seasonal flu vaccine was about 36% more effective than a standard egg-derived equivalent during the 2017-18 US flu season, according to findings from a large study published today in Clinical Infectious Diseases.
An international team of surgeons this week released a set of recommendations for preventing surgical-site infections (SSIs) that aim to improve patient outcomes, reduce unnecessary antibiotic exposure, and curb antibiotic resistance in low- and middle-income countries (LMICs).
The World Health Organization's (WHO's) Special Programme for Research and Training in Tropical Diseases (TDR) announced late last week that 13 projects from 7 countries have been awarded funding for research on antimicrobial resistance (AMR).